Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
17 angezeigte Treffer · Seite 1, keine Gesamtzahl für „until“
Suchtreffer
Begriffe & Kennungen
Adcetris · 4.8 · Among patients who experienced peripheral neuropathy, the median follow up time from end of treatment until la
Eintrag öffnenAdcetris · 4.8 · Among patients who experienced peripheral neuropathy, the median follow up time from end of treatment until la
Eintrag öffnenAubagio · 4.3 · 3 Patients with severe active infection until resolution (see section 4.4).
Eintrag öffnenBusulfan Fresenius Kabi · 4.8 · The treatment-related mortality/non-relapse mortality (TRM/NRM) reported until day+100 post- transplant has al
Eintrag öffnenEnzalutamide Viatris · 4.5 · The full induction potential of enzalutamide may not occur until approximately 1 month after the start of trea
Eintrag öffnenGazyvaro · 4.5 · Vaccination with live virus vaccines is not recommended during treatment and until B-cell recovery because of
Eintrag öffnenHemlibra · 4.8 · * An instance of aPCC treatment is defined as all doses of aPCC received by a patient, for any reason, until t
Eintrag öffnenLemtrada · 4.3 · Patients with severe active infection until complete resolution.
Eintrag öffnenNaglazyme · 4.8 · Infusion reactions, defined as adverse reactions occurring during Naglazyme infusions or until the end of the
Eintrag öffnenNeparvis · 4.5 · 7 therapy must not be started until 36 hours after the last dose of sacubitril/valsartan (see sections 4.2 and
Eintrag öffnenPylobactell · 4.5 · Suppression of H. pylori might give false negative results. Therefore, the test must not be used until four we
Eintrag öffnenQarziba (previously Dinutuximab beta EUSA and Dinutuximab beta Apeiron) · 4.5 · Vaccinations Vaccinations should be avoided during administration of dinutuximab beta until 10 weeks after the
Eintrag öffnenViramune · 4.3 · Patients with severe hepatic impairment (Child-Pugh C) or pre-treatment ASAT or ALAT > 5 ULN until baseline AS
Eintrag öffnenViramune · 4.3 · Patients with severe hepatic impairment (Child-Pugh C) or pre-treatment ASAT or ALAT > 5 ULN until baseline AS
Eintrag öffnenViramune · 4.3 · Patients with severe hepatic impairment (Child-Pugh C) or pre-treatment ASAT or ALAT > 5 ULN until baseline AS
Eintrag öffnenXtandi · 4.5 · The full induction potential of enzalutamide may not occur until approximately 1 month after the start of trea
Eintrag öffnenXtandi · 4.5 · The full induction potential of enzalutamide may not occur until approximately 1 month after the start of trea
Eintrag öffnen